The efficacy and safety of apatinib in patients with metastatic colorectal cancer refractory to standard therapies.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15003
Abstract: e15003Background: Colorectal cancer is the third most frequent cancer and the fourth most frequent cause of cancer-related death worldwide.25% of patients with colorectal cancer have metastatic dis... read more here.
Keywords: safety apatinib; apatinib patients; efficacy safety; colorectal cancer ... See more keywords